The Medicines Company (NASDAQ:MDCO)

CAPS Rating: 4 out of 5

A pharmaceutical company provides innovative, cost effective acute care hospital products to the worldwide hospital marketplace.


Player Avatar agard43 (< 20) Submitted: 3/22/2007 10:31:33 PM : Underperform Start Price: $25.17 MDCO Score: +55.41 "There still seems to be a lot of hope built into the stock price. As Morgan Stanley analyst Stephen Herr wrote this week, "if the patent life is not extended, this stock looks broadly overvalued."

Featured Broker Partners